RxElite Subsidiary FineTech Pharmaceutical, Ltd. President, Speaker at EBRD Panel on "High Tech -- High Stakes" for European Emerging Growth Countries in the Global Marketplace

MERIDIAN, ID--(Marketwire - June 09, 2008) - RxElite, Inc. (OTCBB: RXEI), a developer, manufacturer, and marketer of specialty generic prescription drug products, was honored that Dr. Arie Gutman, a board member and President of its FineTech subsidiary, had been selected as a participant in a panel discussion attended by more than a hundred bankers, entrepreneurs and investors from Eastern Europe at this year's annual meeting of the European Bank for Reconstruction and Development (EBRD).